NCT05908864View on ClinicalTrials.gov

Nebulized Versus Intravenous Magnesium Sulfate in Treatment of Asthma Exacerbation

CompletedOBSERVATIONAL

Enrollment

123

Participants

Timeline

Start Date

October 30, 2018

Primary Completion Date

November 22, 2019

Study Completion Date

December 15, 2020

Conditions

Asthma Attack

Interventions

DRUG

Magnesium sulfate

Blood pressure, respiratory rate, pulse, peak expiratory flow rate (PEFR) measurement using a peak flowmeter, Fischl index and need for hospitalization in patients with acute bronchial asthma were done

Trial Locations (1)

62521

Faculty of Medicine Beni-suef university, Banī Suwayf

All Listed Sponsors

lead

Beni-Suef University

OTHER

NCT05908864 - Nebulized Versus Intravenous Magnesium Sulfate in Treatment of Asthma Exacerbation | Biotech Hunter | Biotech Hunter